Lamotrigine
Home / API - Commercial / Lamotrigine
CAS No.
84057-84-1
Therapeutic Category
- Anti-convulsant
Innovator Brand
LAMICTAL
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Lamotrigine is indicated as adjunctive therapy for the following seizure types in patients ≥2 years of age: partial seizures, primary generalized tonic-clonic seizures, and generalized seizures due to lennox-gastaut syndrome.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.